eater China region and the U.S., including cross-border mergers and acquisitions, private equity and venture capital investments, capital markets, joint venture and other forms of foreign investments, branch operations, spin-offs, and intellectual property and employment benefits counseling. The practice performs the corporate and securities work for many notable U.S.- or Hong Kong-listed public companies with a significant Chinese component to their management and operations, including Ambow Education Holdings, Marvell Technology Group, Semiconductor Manufacturing International Corporation (SMIC), Spreadtrum Communications, Tencent Holdings, and UT Starcom. In addition, the China team frequently collaborates with the firm's U.S.-based litigation department to represent clients headquartered in China in patent, securities, employment, and other litigation and arbitration matters.
The new office is located at Suite 504, Two Exchange Square, 8 Connaught Place, Central, Hong Kong. The main office phone number is +852 2168 0700, and the fax is +852 2168 0701.
About Wilson Sonsini Goodrich & Rosati
Wilson Sonsini Goodrich & Rosati's broad range of services and legal disciplines is focused on serving the principal challenges faced by the management and boards of directors of business enterprises. The firm is nationally recognized as a leader in the fields of corporate governance and finance, mergers and acquisitions, private equity, securities class action litigation, employment law, intellectual property, and antitrust, among many other areas of law. In addition to the newly opened Hong Kong location, Wilson Sonsini Goodrich & Rosati has offices in Austin, New York, Palo Alto, San Diego, San Francisco, Seattle, Shanghai, and Washington, D.C. For additional information, please visit www.wsgr.com.
Page: 1 2 Related biology technology :1
|SOURCE Wilson Sonsini Goodrich & Rosati|
Copyright©2010 PR Newswire.
All rights reserved
. Jerome Wilson Joins PRA Internationals Late Phase Service Group2
. Dynamic Ventures Corporations Information To Be Available Through Standard & Poors Market Access Program3
. WAVE Conference and Exhibition 2011 Taking Products to Market incorporating Micro & Nano Technology4
. Burrill & Company CEO and Genzyme Executive Join BVGH Board of Directors5
. Genesis Biopharma to Present at the Informed Investors Forum Biotech, Healthcare & Pharma Virtual Conference on October 136
. Reportlinker Adds Biobanking for Medical R&D: Technology and Market 2010-20257
. Johnson & Johnson and Crucell Reach Agreement on Intended Public Offer of Euro 24.75 per Ordinary Share of Crucell8
. Vaccinogen Names Veteran Biotech Executive Michael Kranda President & CEO9
. ISTA Pharmaceuticals Highlights Clinical Data from REMURA™ Phase 2 Study Presented at the 6th International Conference on the Tear Film & Ocular Surface10
. Kincannon & Reed Promotes Jon Leafstedt to Managing Partner11
. Frost & Sullivan Commends Isobionics for Technology Innovation